Genetics factors in pathogenesis of lupus erythematosus;Genetyczne uwarunkowania w patogenezie tocznia rumieniowatego układowego

Reumatologia

Volumn 42, Issue 4, 2004, Pages 567-572

  Skrȩtkowicz, Jadwiga ^a   Skrȩtkowicz Szarmach, Kamila ^a   Rychlik Sych, Mariola ^a  

^a Zaklad Farmakodynamiki Katedry B   (Poland)

Author keywords

Genetics; Pathogenesis; Systemic lupus erythematosus

Indexed keywords

FC RECEPTOR;

ALLELE; AUTOIMMUNE DISEASE; ENVIRONMENTAL FACTOR; GENE LOCUS; HEREDITY; HLA SYSTEM; HUMAN; PATHOGENESIS; REVIEW; RHEUMATIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 12344249613     PISSN: 00346233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Ahearn J.M., Provost T.T., Dorsch C.A. et al.: Interrelationships of HLA-DR, MB, and MT phenotypes, autoantibody expression, and clinical features in systemic lupus erythematosus. Arthritis Rheum., 1982, 25, 1031.
2. Ahmed S., Ihara K., Kanemitsu S. et al.: Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population. Rheumatology 2001, 40, 662-667.
3. Arnett F.C.: The genetics of Human lupus. In: Dubois' Lupus Erythematosus, Wallace DJ, Hahn BH (eds). Williams and Wilkins, Baltimor 1997, 77-117.
4. Cohen P.L., Eisenberg R.A.: Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Ann. Rev. Immunol., 1991, 9, 243.
5. D'Alfonso S., Rampi M., Bocchio D. et al.: Systemic lupus erythematosus candidate genes in Italian population: evidence for a significant association with interleukin-10. Arthritis Rheum., 2000, 43, 120.
6. Davies E.J., Teh L.S., Ordi-Ros J. et al.: A dysfunctional allele of the mannose binding protein gene associates with systemic lupus eythematosus in a Spanish population. J. Rheumatol., 1997, 24, 485.
7. Dijstelbloem H.M., Bijl M., Fijnheer R. et al.: Fc gamma receptor polymorphisms in systemic lupus erythematosus. Association with disease and in vivo clearance of immune complexes. Arthritis Rheum., 2000, 43, 2793.
8. Duits A.J., Bootsma H., Derksen R.H.: Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum., 1995, 39, 1832.
9. Enenkel B., Jung D., Frey J.: Molecular basis of IgG Fc receptor III defect in a patient with systemic lupus erythematosus. Eur. J. Immunol., 19991, 21, 659.
10. Gaffney P.M., Ortmann W.A., Selby S.A. et al.: Genome screening in human systemic lupus erythematosus: results from a second Minnesota cohort and combined analyses of 187 sib-pair families. Am. J. Hum. Genet., 2000, 66, 547.
11. Gladman K.K., Urowitz M.B., Darlinkton C.A.: Disease expression and class II HLA antigens in systemic lupus erythematosus. Lupus 1999, 8, 466.
12. Gray-McGuire C., Moser K.L., Gaffney P.M. et al.: Genome scan of human systemic lupus erythematosus by regression modeling: evidence of linkage and epistatis at 4p16-15.2. Am. J. Hum. Genet., 2000, 67, 1460.
13. Grondal G., Gunnarsson I., Ronnelied J. et al.: Cytokine production, serum levels and disease activity in systemic lupus erythematosus. Clin. Exp. Rheumatol., 2000, 18, 565.
14. Grumet F.C., Coukell A., Bodmer J.G. et al.: Histocompability (HLA) antigens associated with systemic lupus erythematosus. A possible genetic predisposition to disease. N. Engl. J. Med., 1971, 285, 193.
15. Hagiwara E., Gourley M.F., Lee S. et al.: Disease severity in patients with systemic lupus erythematosus correlates with an increased ration of IL-10: IFN gamma-secreting cells in the peripheral blood. Arthritis Rheum., 1996, 39, 379.
16. Hashimoto H., Tsuda H., Matsumoto T. et al.: HLA antigens associated with systemic lupus erythematosus in Japan. J. Rheumatol., 1985, 12, 919.
17. Hatta Y., Tsuchiya N., Ohashi J. et al.: Association of Fc gamma receptor IIIB, but not Fc gamma receptor IIA and IIIA, polymorphism with systemic lupus erythematosus in Japanese. Genes. Immun., 1999, 1, 53.
18. Kachru R.B., Sequeira W., Mittal K.K. et al.: A significant increase of GLA-DR3 and DR2 in systemic lupus erythematosus a mongblacks. J. Rheumatol., 1984, 11, 471.
19. Kameda S., Naito S. et al.: HLA antigens of patients with systemic lupus eythematosus in Japan. Tissue Antigens 1982, 20, 221.
20. Klinger M.: Toczniowe zapalenie nerek; patogeneza, diagnostyka i leczenie. W: Postȩpy w nefrologii i nadciśnieniu tȩtniczym. Wiȩcek A., Kokot F. (red.). Medycyna Praktyczna, Kraków 2001, 15.
21. Lindqvist A.K., Steinsson K., Johanneson B. et al.: A susceptibility locus for human systemic lupus erythematosus (hSLE1) on chromosome 2q. J. Autoimmun., 2000, 14, 169.
22. Lipsker D.M., Schreckenberg-Gilliot C., Uring-Lambert B. et al.: Lupus erythematosus associated with genetically determined deficiency of the second component of the complement. Arch. Dermatol., 2000, 136, 1508.
23. Manger K., Repp R., Spriewald et al.: Fcγ receptor IIa polymorphism in Caucasian patients with systemic lupus erythematosus. Arthritis Rheum., 1998, 41, 1181.
24. Mehra N.K., Pande I., Taneja V et al.: Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus in northern India. Lupus, 1993, 2, 313.
25. Mehrian R., Quismorio F.P., Strassman G. et al.: Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus. Arthritis Rheum., 1998, 41, 596.
26. Moser K.L., Neas R.B., Salmon J.B. et al.: Genome scan of human systemic lupus erythematosus:evidence for linkage on chromosome 1q in African-American pedigrees. Proc. Natl. Acad. Sci. USA, 1998, 95, 14869.
27. Nath S.K., Kelly J.A., Namjou B. et al.: Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo related systemic lupus erythematosus. Am. J. Hum. Genet., 2001, 69, 1401.
28. Naves M., Hajeer A.H., Teh L.S. et al.: Complement C4B null allele status confers risk for systemic lupus erythematosus in a Spanish population. Eur. J. Immunogenet, 1998, 25, 317.
29. Ory P.A., Clark M.R., Kwoh E.E. et al.: Sequences of complementary DNAs that encode the NA1 and NA2 forms of Fc receptor III on human neutrophils. J. Clin. Invest., 1989, 84, 1688.
30. Petri M., Watson R., Winkelstein J. et al.: Clinical expression of systemic lupus erythematosus in patients with C4 deficiency. Medicine 1993, 72, 236.
31. Provost T.T., Arnett F.C., Reichlin M.: Homozygous C2 deficiency, lupus erythematosus, and anti-Ro (SSA) antibodies. Arthritis Rheum., 1983, 26, 1279.
32. Ratnoff W.D.: Inherited deficiencies of complement in rheumatic diseases. Rheum. Dis. Clin. North Am., 1996, 22, 75.
33. Reid K.M.B.: Deficiency of the first component of human complement. In: Immunodeficiencies, Rosen F.S., Seligmann M. Harwood Academic Publishers Philadelphia 1993, 283.
34. Salmon J.E., Edberg J.C., Kimberly R.P.: Fc gamma receptor III on human neutrophils. Allelic variants have functionally distinct capacities. J. Clin. Invest., 1990, 85, 1287.
35. Salmon J.E., Millard S., Schachter L.A. et al.: FcγRIIA alleles are heritable risk factors for lupus nephritis in African Americans. J. Clin. Invest., 1996, 97, 1348.
36. Salmon J.E., Ng S., Yoo D.H. et al.: Altered distribution of Fc gamma receptor IIIA alleles in a cohort of Korean patients with lupus nephritis. Arthritis Rheum., 1999, 42, 818.
37. Smyth L.J., Snowden N., Carthy D. et al.: Fc gamma RIIa polymorphism in systemic lupus erythematosus. Ann. Rheum. Dis., 1997, 56, 744.
38. Stevens A., Ray D., Alansari A. et al.: Characterization of a prolactin gene polymorphism and its association with systemic lupus erythematosus. Arthritis Rheum., 2001, 44, 2358.
39. Sullivan K.E., Petri M.A., Schmeckpeper B.J. et al.: Prevalence of a mutation causing C2 deficiency in systemic lupus erythematosus. J. Rheumatol., 1994, 21, 2144.
40. Sullivan K.E., Wooten C., Goldman D. et al.: Mannose-binding protein polymorphism in black patients with systemic lupus erythematosus. Arthritis Rheum., 1996, 39, 2046.
41. Sysa-Jȩdrzejowska A.: Choroby tkanki ła̧cznej. W: Immunologia kliniczna, Kowalski M. (red.). Mediton, Łódź 2000, 341.
42. Takahashi T., Tanaka M., Brannan C.I. et al.: Generalized lymphoproliferative disease in mice caused by a point mutation in the fas ligand. Cell, 1994, 76, 969.
43. Theofilopoulos A.N., Dixon F.J.: Murine models of systemic lupus erythematosus. Adv. Immunol., 1985, 37, 269.
44. Topaloglu R., Bakkaloglu A., Slingsby J.H. et al.: Survey of Turkish systemic lupus erythematosus patients for a particular mutation of C1Q deficiency. Clin. Exp. Rheumatol., 2000, 18, 75.
45. Tsao B.P., Cantor R.M., Kalunian K.C. et al.: Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligorelated systemic lupus erythematosus. Am. J. Hum. Genet., 2001, 69, 1401.
46. Whittingham S., Mathews J.D., Schanfield M.S. et al.: HLA and Gm genes in systemic lupus erythematosus. Tissue Antigens, 1983, 21, 50.
47. Wu J., Edberg J.C., Redecha P.B. et al.: A novel polymorphism of FcγRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J. Clin. Invest., 1997, 100, 1059.
48. Wu J., Wilson J., He J. et al.: Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J. Clin. Invest., 1996, 98, 1107.
49. Zimmermann-Górska I.: Toczeń rumieniowaty układowy. W: Reumatologia, Mackiewicz S., Zimmermann-Górska I. (red.). Wyd. Lekarskie PZWL, Warszawa 1995, 123.
50. Zuniga J., Vargas-Alarcon G., Hernandez-Pacheco G. et al.: Tumor necrosis factor-alpha promotor polymorphisms in Mexican patients with systemic lupus erythematosus (SLE). Genes Immunol., 2001, 2, 363.